ICD-10 Coding for Lymph Node Metastasis(C77.0, C77.0B, C77.0S)
Learn about ICD-10 coding for lymph node metastasis, including code ranges, documentation requirements, and common pitfalls.
Complete code families applicable to Lymph Node Metastasis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C77.0 | Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | Use when metastasis to cervical lymph nodes is confirmed. |
|
| C77.1 | Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes | Use for confirmed metastasis to intrathoracic lymph nodes. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutLymph Node Metastasis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Lymph Node Metastasis.
Using history codes for active treatment
Impact
Clinical: Misrepresentation of patient's current treatment status., Regulatory: Potential non-compliance with coding standards., Financial: Incorrect billing and potential claim denials.
Mitigation
Verify current treatment status before coding., Use active treatment codes when applicable.
Incorrect sequencing of primary and secondary codes
Impact
Reimbursement: Incorrect sequencing can lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Always sequence the code for the site of metastasis first when treatment is directed at the metastatic site.
Sequencing errors
Impact
Incorrect sequencing of primary and secondary codes.
Mitigation
Regular training on sequencing rules.